Table 2.
General outcome measures at baseline and after 3 and 6 months in patientsa recovering from COVID-19 receiving primary allied health care in a Dutch prospective cohort study.
| General outcome measures | Baseline (T0) | 3 months (T1) | 6 months (T2) | |
| Participation | ||||
|
|
Sample population, n/N (%) | 1271/1451 (87.6) | 945/1451 (65.1) | 921/1451 (63.5) |
|
|
USER-Pb frequencies subscale score, mean (SD) | 27.5 (10.3) | 30.5 (10.5) | 31.3 (10.1) |
|
|
USER-P restrictions subscale score, mean (SD) | 65.8 (20.1) | 73.6 (19.4) | 77.3 (19.8) |
|
|
USER-P satisfaction subscale score, mean (SD) | 48.6 (17.8) | 54.8 (19.5) | 58.1 (19.9) |
| HRQoLc | ||||
|
|
Sample population, n/N (%) | 1289/1451 (88.8) | 954/1451 (65.7) | 932/1451 (64.2) |
|
|
EQ-VASd score, mean (SD) | 55.5 (17.8) | 64.3 (18.2) | 67.4 (19.1) |
| Fatigue | ||||
|
|
Sample population, n/N (%) | 1281/1451 (88.3) | 951/1451 (65.5) | 929/1451 (64.0) |
|
|
FSSe score, mean (SD) | 5.6 (1.0) | 5.2 (1.2) | 4.9 (1.3) |
|
|
≥4 points, n (%) | 1205 (94.1) | 815 (85.7) | 742 (79.9) |
| Physical functioning | ||||
|
|
Sample population, n/N (%) | 1279/1451 (88.1) | 951/1451 (65.5) | 929/1451 (64.0) |
|
|
PROMIS-PF-10bf score, mean (SD) | 37.7 (6.0) | 41.5 (7.6) | 43.5 (8.50) |
|
|
100% impaired, limited, or restricted, n (%) | 2 (0.2) | 2 (0.2) | 140 (15.1) |
|
|
80%-99% impaired, limited, or restricted, n (%) | 427 (33.4) | 176 (18.5) | 211 (22.7) |
|
|
60%-79% impaired, limited, or restricted, n (%) | 452 (35.3) | 276 (29.0) | 202 (21.7) |
|
|
40%-59% impaired, limited, or restricted, n (%) | 259 (20.3) | 227 (23.9) | 157 (16.9) |
|
|
20%-39% impaired, limited, or restricted, n (%) | 97 (7.6) | 133 (14.0) | 150 (16.1) |
|
|
1%-19% impaired, limited, or restricted, n (%) | 39 (3.0) | 95 (10.0) | 72 (7.8) |
|
|
0% impaired, limited, or restricted, n (%) | 4 (0.3) | 42 (4.4) | 140 (15.1) |
| Psychological well-beingg (anxiety) | ||||
|
|
Sample population, n/N (%) | 1271/1451 (87.6) | N/Ah | 926/1451 (63.8) |
|
|
HADSi anxiety score, mean (SD) | 7.1 (4.5) | N/A | 6.3 (4.7) |
|
|
≤7 points, n (%) | 746 (58.7) | N/A | 613 (66.2) |
|
|
8-10 points, n (%) | 233 (18.3) | N/A | 143 (15.4) |
|
|
≥11 points, n (%) | 292 (23.0) | N/A | 170 (18.4) |
| Psychological well-being (depression) | ||||
|
|
Sample population, n/N (%) | 1271/1451 (87.6) | N/A | 926/1451 (63.8) |
|
|
HADS depression score, mean (SD) | 7.3 (4.2) | N/A | 5.7 (4.3) |
|
|
≤7 points, n (%) | 689 (54.2) | N/A | 638 (68.9) |
|
|
8-10 points, n (%) | 297 (23.4) | N/A | 151 (16.3) |
|
|
≥11 points, n (%) | 285 (22.4) | N/A | 137 (14.8) |
aData were not fully available for all patients.
bUSER-P: Utrecht Scale for Evaluation of Rehabilitation—Participation.
cHRQoL: health-related quality of life.
dEQ-VAS: EuroQol Visual Analog Scale.
eFSS: Fatigue Severity Scale.
fPROMIS-PF-10b: Patient-Reported Outcomes Measurement Information System Physical Functioning Short Form 10b.
gPsychological well-being was only assessed at baseline (T0) and at 6 months (T2).
hN/A: not applicable.
iHADS: Hospital Anxiety and Depression Scale.